nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—S1PR4—adrenal gland—adrenal gland cancer	0.032	0.0917	CbGeAlD
Fingolimod—S1PR5—adrenal gland—adrenal gland cancer	0.0269	0.0771	CbGeAlD
Fingolimod—CYP4F12—adrenal cortex—adrenal gland cancer	0.0259	0.0743	CbGeAlD
Fingolimod—S1PR3—gonad—adrenal gland cancer	0.0256	0.0735	CbGeAlD
Fingolimod—S1PR3—cardiac atrium—adrenal gland cancer	0.0256	0.0734	CbGeAlD
Fingolimod—SPHK1—gonad—adrenal gland cancer	0.0224	0.0641	CbGeAlD
Fingolimod—S1PR3—adrenal gland—adrenal gland cancer	0.0223	0.064	CbGeAlD
Fingolimod—SPHK1—pituitary gland—adrenal gland cancer	0.0218	0.0625	CbGeAlD
Fingolimod—CYP4F12—cardiac atrium—adrenal gland cancer	0.0215	0.0615	CbGeAlD
Fingolimod—CYP4F12—pituitary gland—adrenal gland cancer	0.021	0.0601	CbGeAlD
Fingolimod—S1PR1—adrenal gland—adrenal gland cancer	0.0197	0.0565	CbGeAlD
Fingolimod—SPHK1—adrenal gland—adrenal gland cancer	0.0195	0.0559	CbGeAlD
Fingolimod—CYP4F12—adrenal gland—adrenal gland cancer	0.0187	0.0537	CbGeAlD
Fingolimod—CYP2E1—urine—adrenal gland cancer	0.0165	0.0473	CbGeAlD
Fingolimod—CYP3A4—urine—adrenal gland cancer	0.0133	0.0381	CbGeAlD
Fingolimod—CYP2D6—urine—adrenal gland cancer	0.0131	0.0375	CbGeAlD
Fingolimod—S1PR1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00375	0.00576	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00375	0.00576	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00375	0.00576	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00354	0.00544	CbGpPWpGaD
Fingolimod—CYP4F12—Biological oxidations—POMC—adrenal gland cancer	0.00351	0.00539	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00341	0.00523	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.0034	0.00523	CbGpPWpGaD
Fingolimod—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00336	0.00517	CbGpPWpGaD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—BRAF—adrenal gland cancer	0.00332	0.0051	CbGpPWpGaD
Fingolimod—CYP2E1—adrenal gland—adrenal gland cancer	0.00316	0.00905	CbGeAlD
Fingolimod—CYP4F12—Metabolism—SDHB—adrenal gland cancer	0.00314	0.00482	CbGpPWpGaD
Fingolimod—CYP4F2—Biological oxidations—POMC—adrenal gland cancer	0.00303	0.00465	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00292	0.00449	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—CTNNB1—adrenal gland cancer	0.00272	0.00417	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—SDHB—adrenal gland cancer	0.00271	0.00416	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00262	0.00403	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—REN—adrenal gland cancer	0.00259	0.00398	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00257	0.00395	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—CTNNB1—adrenal gland cancer	0.00256	0.00394	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00252	0.00388	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00252	0.00388	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00251	0.00386	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00247	0.0038	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00247	0.0038	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—GNAS—adrenal gland cancer	0.00236	0.00362	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00233	0.00358	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—SDHB—adrenal gland cancer	0.00233	0.00358	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—GNRHR—adrenal gland cancer	0.0023	0.00353	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00229	0.00352	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00229	0.00352	CbGpPWpGaD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00228	0.0035	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00227	0.00349	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00227	0.00349	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00225	0.00345	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00225	0.00345	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00225	0.00345	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00222	0.0034	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00222	0.0034	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00221	0.00339	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00221	0.00339	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00214	0.00329	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00213	0.00327	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00208	0.0032	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—TSHR—adrenal gland cancer	0.00208	0.00319	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00206	0.00317	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00206	0.00316	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00206	0.00316	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00204	0.00313	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—RRM1—adrenal gland cancer	0.00202	0.00311	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—SDHD—adrenal gland cancer	0.00202	0.00311	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00201	0.00309	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00201	0.00309	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00201	0.00308	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00201	0.00308	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—TSHR—adrenal gland cancer	0.002	0.00308	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—TSHR—adrenal gland cancer	0.002	0.00308	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.002	0.00307	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00194	0.00297	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00194	0.00297	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00187	0.00287	CbGpPWpGaD
Fingolimod—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00184	0.00283	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00183	0.00281	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00182	0.0028	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00182	0.00279	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00178	0.00273	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00176	0.0027	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—SDHD—adrenal gland cancer	0.00175	0.00268	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—RRM1—adrenal gland cancer	0.00175	0.00268	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00166	0.00254	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—POMC—adrenal gland cancer	0.00159	0.00244	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00156	0.00239	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—POMC—adrenal gland cancer	0.00153	0.00235	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—POMC—adrenal gland cancer	0.00153	0.00235	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—MED12—adrenal gland cancer	0.00151	0.00232	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—RRM1—adrenal gland cancer	0.0015	0.0023	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—SDHD—adrenal gland cancer	0.0015	0.0023	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00149	0.00229	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00144	0.00221	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00144	0.00221	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00139	0.00214	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—POMC—adrenal gland cancer	0.00139	0.00213	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—GNRH1—adrenal gland cancer	0.00138	0.00212	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00134	0.00206	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00134	0.00206	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00133	0.00205	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00133	0.00204	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00133	0.00204	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0013	0.002	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—MED12—adrenal gland cancer	0.0013	0.002	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—IGF2—adrenal gland cancer	0.00129	0.00199	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00128	0.00197	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00128	0.00197	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CDC42—adrenal gland cancer	0.00127	0.00194	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SPRY2—adrenal gland cancer	0.00126	0.00194	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TSHR—adrenal gland cancer	0.00123	0.00189	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CDC42—adrenal gland cancer	0.00122	0.00187	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CDC42—adrenal gland cancer	0.00122	0.00187	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00122	0.00187	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00121	0.00186	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SPRY2—adrenal gland cancer	0.00121	0.00186	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—GNAS—adrenal gland cancer	0.00121	0.00186	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00121	0.00185	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TSHR—adrenal gland cancer	0.00118	0.00182	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TSHR—adrenal gland cancer	0.00118	0.00182	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00116	0.00179	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—GNAS—adrenal gland cancer	0.00116	0.00179	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00116	0.00179	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00116	0.00179	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MEN1—adrenal gland cancer	0.00116	0.00177	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—MED12—adrenal gland cancer	0.00112	0.00172	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MEN1—adrenal gland cancer	0.00111	0.00171	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MEN1—adrenal gland cancer	0.00111	0.00171	CbGpPWpGaD
Fingolimod—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00111	0.0017	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00111	0.0017	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.0011	0.00169	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PRKACA—adrenal gland cancer	0.0011	0.00169	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TSHR—adrenal gland cancer	0.00107	0.00165	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00107	0.00164	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00106	0.00162	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00106	0.00162	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MEN1—adrenal gland cancer	0.00101	0.00155	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.001	0.00154	CbGpPWpGaD
Fingolimod—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000993	0.00152	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000975	0.0015	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TSHR—adrenal gland cancer	0.000951	0.00146	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PRKACA—adrenal gland cancer	0.00095	0.00146	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000928	0.00143	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—POMC—adrenal gland cancer	0.000897	0.00138	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MEN1—adrenal gland cancer	0.000894	0.00137	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GNAS—adrenal gland cancer	0.000892	0.00137	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PRKACA—adrenal gland cancer	0.000882	0.00135	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ABCB1—adrenal gland cancer	0.000875	0.00134	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—POMC—adrenal gland cancer	0.000864	0.00133	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—POMC—adrenal gland cancer	0.000864	0.00133	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000864	0.00133	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000849	0.0013	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PRKACA—adrenal gland cancer	0.000849	0.0013	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PRKACA—adrenal gland cancer	0.000816	0.00125	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—POMC—adrenal gland cancer	0.000815	0.00125	CbGpPWpGaD
Fingolimod—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000805	0.00124	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000797	0.00122	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—POMC—adrenal gland cancer	0.000784	0.0012	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—POMC—adrenal gland cancer	0.000784	0.0012	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000784	0.0012	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000771	0.00118	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GNAS—adrenal gland cancer	0.00077	0.00118	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ABCB1—adrenal gland cancer	0.000755	0.00116	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDC42—adrenal gland cancer	0.000748	0.00115	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IGF2—adrenal gland cancer	0.000721	0.00111	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDC42—adrenal gland cancer	0.00072	0.00111	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDC42—adrenal gland cancer	0.00072	0.00111	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—GNAS—adrenal gland cancer	0.000715	0.0011	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—POMC—adrenal gland cancer	0.000712	0.00109	CbGpPWpGaD
Fingolimod—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000704	0.00108	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000697	0.00107	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IGF2—adrenal gland cancer	0.000694	0.00107	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IGF2—adrenal gland cancer	0.000694	0.00107	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GNAS—adrenal gland cancer	0.000688	0.00106	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GNAS—adrenal gland cancer	0.000688	0.00106	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000682	0.00105	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000671	0.00103	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IGF1R—adrenal gland cancer	0.000671	0.00103	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GNAS—adrenal gland cancer	0.000661	0.00102	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDC42—adrenal gland cancer	0.000654	0.001	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ABCB1—adrenal gland cancer	0.000649	0.000997	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IGF2—adrenal gland cancer	0.00063	0.000968	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—GNAS—adrenal gland cancer	0.000625	0.00096	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CTNNB1—adrenal gland cancer	0.000617	0.000947	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000609	0.000936	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—POMC—adrenal gland cancer	0.0006	0.000922	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TERT—adrenal gland cancer	0.0006	0.000922	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDC42—adrenal gland cancer	0.000579	0.000889	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TERT—adrenal gland cancer	0.000578	0.000887	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TERT—adrenal gland cancer	0.000578	0.000887	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000571	0.000877	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IGF2—adrenal gland cancer	0.000558	0.000857	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GNAS—adrenal gland cancer	0.000553	0.000849	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000539	0.000828	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TERT—adrenal gland cancer	0.000525	0.000806	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—BAD—adrenal gland cancer	0.000522	0.000802	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—POMC—adrenal gland cancer	0.000518	0.000796	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—BAD—adrenal gland cancer	0.000503	0.000772	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—BAD—adrenal gland cancer	0.000503	0.000772	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—POMC—adrenal gland cancer	0.000481	0.000739	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS2—adrenal gland cancer	0.000479	0.000735	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—BRAF—adrenal gland cancer	0.000475	0.00073	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TERT—adrenal gland cancer	0.000464	0.000713	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—POMC—adrenal gland cancer	0.000463	0.000711	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—POMC—adrenal gland cancer	0.000463	0.000711	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000461	0.000707	CbGpPWpGaD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00046	0.000707	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—BRAF—adrenal gland cancer	0.000457	0.000703	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—BRAF—adrenal gland cancer	0.000457	0.000703	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—BAD—adrenal gland cancer	0.000456	0.000701	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—POMC—adrenal gland cancer	0.000445	0.000684	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000443	0.000681	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000443	0.000681	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	0.000427	0.000656	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—POMC—adrenal gland cancer	0.000421	0.000646	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—BRAF—adrenal gland cancer	0.000415	0.000638	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—adrenal gland cancer	0.000413	0.000635	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—BAD—adrenal gland cancer	0.000404	0.00062	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000403	0.000618	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SDHB—adrenal gland cancer	0.000382	0.000587	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000373	0.000573	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—POMC—adrenal gland cancer	0.000372	0.000572	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—BRAF—adrenal gland cancer	0.000368	0.000565	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—adrenal gland cancer	0.000355	0.000545	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000343	0.000528	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000331	0.000508	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000331	0.000508	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000303	0.000466	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.0003	0.000461	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—adrenal gland cancer	0.000272	0.000418	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000271	0.000416	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000266	0.000408	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—adrenal gland cancer	0.000262	0.000402	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—adrenal gland cancer	0.000262	0.000402	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—RRM1—adrenal gland cancer	0.000246	0.000378	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SDHD—adrenal gland cancer	0.000246	0.000378	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—adrenal gland cancer	0.000238	0.000365	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—adrenal gland cancer	0.000228	0.000351	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—adrenal gland cancer	0.00022	0.000338	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—adrenal gland cancer	0.00022	0.000338	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—adrenal gland cancer	0.000211	0.000323	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—adrenal gland cancer	0.0002	0.000307	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000198	0.000305	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MED12—adrenal gland cancer	0.000184	0.000282	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000177	0.000272	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—adrenal gland cancer	0.000177	0.000271	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000175	0.000268	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000175	0.000268	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	0.000134	0.000206	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.00013	0.0002	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000114	0.000175	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000114	0.000175	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GNAS—adrenal gland cancer	0.000109	0.000167	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	0.000107	0.000164	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	9.5e-05	0.000146	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MED12—adrenal gland cancer	8.52e-05	0.000131	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GNAS—adrenal gland cancer	7.7e-05	0.000118	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	7.56e-05	0.000116	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—POMC—adrenal gland cancer	7.31e-05	0.000112	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	6.21e-05	9.54e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	5.83e-05	8.95e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—POMC—adrenal gland cancer	5.19e-05	7.97e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GNAS—adrenal gland cancer	5.04e-05	7.73e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	4.94e-05	7.59e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	4.14e-05	6.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—POMC—adrenal gland cancer	3.39e-05	5.21e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	2.7e-05	4.15e-05	CbGpPWpGaD
